[Federal Register Volume 83, Number 25 (Tuesday, February 6, 2018)]
[Notices]
[Pages 5264-5265]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-02268]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Immunization Practices (ACIP)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the 
Centers for Disease Control and Prevention (CDC), announces the 
following meeting of the Advisory Committee on Immunization Practices 
(ACIP). This meeting is open to the public, limited only by room 
seating. Time will be available for public comment. The public is 
welcome to submit written comments in advance of the meeting. Comments 
should be submitted in writing by email to the contact person listed 
below. The deadline for receipt is February 14, 2018. Written comments 
must include full name, address, organizational affiliation, email 
address of the speaker, topic being addressed and specific comments. 
Written comments must not exceed one single-spaced typed page with 1-
inch margins containing all items above. Only those written comments 
received 10 business days in advance of the meeting will be included in 
the official record of the meeting. Public comments made in attendance 
must be no longer than 3 minutes and the person giving comments must 
attend the public comment session at the start time listed on the 
agenda. Time for public comments may start before the time indicated on 
the agenda. The meeting will be webcast live via the World Wide Web; 
for instructions and more information on ACIP please visit the ACIP 
website: http://www.cdc.gov/vaccines/acip/index.html.

DATES: The meeting will be held on February 21, 2018, 8:00 a.m. to 5:45 
p.m., EDT, and February 22, 2018, 8:00 a.m. to 12:30 p.m. EDT.

ADDRESSES: CDC, 1600 Clifton Road, NE, Tom Harkin Global Communications 
Center, Kent `Oz' Nelson Auditorium, Atlanta, Georgia 30329.

FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, ACIP Committee 
Management Specialist, CDC, NCIRD. Email [email protected].

SUPPLEMENTARY INFORMATION: 
    Purpose: The committee is charged with advising the Director, CDC, 
on the use of immunizing agents. In addition, under 42 U.S.C. 1396s, 
the committee is mandated to establish and periodically review and, as 
appropriate, revise the

[[Page 5265]]

list of vaccines for administration to vaccine-eligible children 
through the Vaccines for Children (VFC) program, along with schedules 
regarding dosing interval, dosage, and contraindications to 
administration of vaccines. Further, under provisions of the Affordable 
Care Act, section 2713 of the Public Health Service Act, immunization 
recommendations of the ACIP that have been approved by the Director of 
the Centers for Disease Control and Prevention and appear on CDC 
immunization schedules must be covered by applicable health plans.
    Matters To Be Considered: The agenda will include discussions on 
Influenza vaccines, evidence based recommendations, anthrax vaccine, 
Japanese encephalitis vaccines, hepatitis vaccines, human 
papillomavirus vaccines, pneumococcal vaccines, meningococcal disease, 
and an update on vaccines and other biologics for prevention and 
treatment of healthcare-associated infections. A recommendation vote is 
scheduled for hepatitis vaccines and evidence based recommendations. 
Agenda items are subject to change as priorities dictate.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2018-02268 Filed 2-5-18; 8:45 am]
 BILLING CODE 4163-18-P